Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

4 Stocks To Watch Today: ADXS, CAPN, GIMO, ORMP

Published 04/14/2015, 12:59 AM
Updated 07/09/2023, 06:31 AM

It was kind of a crummy market on Monday, particularly at the end of the day. It started off with a bang, rolled over, and closed at the lows. It's nothing to be too concerned about yet, not until we see if there’s any downside follow-through. Meanwhile, a lot of our stocks continue to do great.

Advaxis Inc (NASDAQ:ADXS) is unbelievable. This stock has gone from 2 1/2-3/4 in November to Monday’s close at 21 1/2, a 10-fold increase. It’s long in the tooth, but it has had legs 1 and 2 up, and leg 3 looks like it may be ending. The 17 and 19-dollar swing trades have been met. The high on Monday was 21.53, before backing off. It did come on again, and it did have another successful day. Basically, 10 out of 11 days it’s been up. The OBV is continuing. As long as the rising bottoms continue to rise, we can continue with this stock. The low was 19.20. I would like to stop this under 19 in case it does a couple-point pullback here. If momentum carries it forward, we could see 24-25 in this stock.

Capnia Inc (NASDAQ:CAPN) had a nice day on Monday. It popped out of a wedge, and, although it didn’t close behind the range it did disappoint a little bit. It was up 40 cents, or 6%, on 411,500 shares traded. The volume increased a little. It could be the beginning of a move. We’ll have to keep close tabs on it. Short-term trade consider stopping under the 6-6.15 zone. On the long side, if it gets above the 8 1/4 range, I think it will take off, first the 10 zone, then 12, and then we’ll see what's next.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Gigamon Inc (NYSE:GIMO), a swing trade of ours, extended on Monday, up nearly another 1.00, or 4 1/4%, on 1.1 million shares. That’s the best volume in about 8 weeks. When breaking out more volume is always a good thing. Look for it to head up towards the 26-7 zone.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) had a fantastic day on Monday, with a massive pop of 2.41, or 38.7%, on 2.9 million shares. It didn’t close great. It was 1.20 off the high. Nevertheless, that’s key resistance, and may be the reason it backed off. Let’s see what kind of a consolidation or follow-through it gets, if any. Resistance is obviously up around the 9.85 area. The next targets are 11 1/2 and 14.

Other stocks on Harry’s Charts of the Day included Builders FirstSource Inc (NASDAQ:BLDR), Clovis Oncology Inc (NASDAQ:CLVS), Eagle Pharm (NASDAQ:EGRX), Great Basin Scientific Inc (NASDAQ:GBSN), JetBlue Airways Corporation (NASDAQ:JBLU), Jd.Com Inc Adr (NASDAQ:JD), Jumei International Holding Ltd (NYSE:JMEI), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Natural Health Trend (NASDAQ:NHTC), Recro Pharm (NASDAQ:REPH), Repligen Corporation (NASDAQ:RGEN), Sequenom Inc (NASDAQ:SQNM), Voltari Corporation (VLTC), Vuzix Corp Cmn Stk (NASDAQ:VUZI), and Wayfair Inc (NYSE:W).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.